NCT05628480

Brief Summary

This case-control study is planned to recruit patients who meet the enrollment conditions, receive cardiac surgery (cardiac valve surgery or coronary artery bypass surgery) and cardiopulmonary bypass, and sign the informed consent form in the second ward of adult cardiac surgery, Fuwai Hospital. Use RASS, CAM-ICU scales to evaluate postoperative patients and divide them into delirium and non-delirium groups according to whether they had delirium after surgery. There will be 30 patients in each group. Match the two groups in terms of surgical type, duration of cardiopulmonary bypass, gender and age range (± 3 years). Collect and record the preoperative, intraoperative and postoperative data of the enrolled patients, including cardiopulmonary bypass time, ICU stay time, length of mechanical ventilation, hemodynamics and other data. Fecal and/or blood samples are collected from 60 patients before, immediately after and after operation. The laboratory test and analysis shall be started after the collection of clinical samples. Fecal samples are used for Metagenomics Sequencing and Functional genomics. Blood samples are analyzed by serum metabolomics for changes in intestinal metabolites entering the blood circulation. Simultaneous measurement of IL-6 and TNF in peripheral blood with serum samples- α, IL-1a,IFN-γ and LPS, D-lactic acid and diamine oxidase levels.Use Multi-omics approach to analyze the correlation between intestinal flora diversity, functional gene abundance and blood metabolites, inflammation level and intestinal barrier function, and to find the clinical evidence of the correlation between microbiota-gut-brain axis and the occurrence of POD in patients. Through comprehensive analysis of the research results of this experiment, access to literature, write papers, submit papers and publish relevant papers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 7, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

November 28, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

April 17, 2024

Status Verified

April 1, 2024

Enrollment Period

1.3 years

First QC Date

November 7, 2022

Last Update Submit

April 15, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • postoperative delirium

    Use the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) to identify delirium in critically ill patients.The CAM-ICU consists of four main components:inattention, autonomic instability, disorganized thinking, altered level of consciousness.If patient have 1) acute onset of mental status changes or a fluctuating course and 2)inattention and 3)disorganized thinking or 4)altered level of consciousness, thus the patient can be assessed as postoperative delirium (1+2+3/4=POD).

    1-4 days after cardiac surgery

  • type of postoperative delirium

    The Richmond Agitation Sedation Scale (RASS) is an instrument designed to assess the level of alertness and agitated behavior in critically-ill patients.The RASS is a 10-point scale ranging from -5 to +4. Levels -1 to -5 denote 5 levels of sedation, levels +1 to +4 describe increasing levels of agitation,level 0 is "alert and calm." 1.Hyperactive POD: postoperative delirium patient with RASS scores +1\~+4; 2.Hypoactive POD:Hyperactive POD: postoperative delirium patient with RASS scores -3\~0; 3.Mixed POD: postoperative delirium patient with RASS score fluctuate between positive and negative.

    1-4 days after cardiac surgery

Study Arms (2)

POD group

According to RASS and CAM-ICU scales, patients who suffer from post-cardiac surgery delirium in ICU will be include into POD group

Non-POD group

According to RASS and CAM-ICU scales,patients who do not judge as post-cardiac surgery delirium in ICU will be include into non-POD group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients who meet the enrollment conditions, receive cardiac surgery (heart valve surgery or coronary artery bypass surgery) and cardiopulmonary bypass (CPB) in the Department of Cardiovascular Surgery, Fuwai Hospital, Chinese Academy of Medical Sciences.

You may qualify if:

  • elective cardiac valve surgery or coronary artery bypass grafting
  • open heart surgery under hypothermic cardiopulmonary bypass under intravenous and/or inhalation general anesthesia
  • No history of delirium attack, no cognitive impairment, normal speech, and certain ability of speaking and reading
  • age\>18
  • Informed consent of patients, voluntary participation (or consent of family members), and signing of informed consent

You may not qualify if:

  • There are organic brain diseases (preoperative brain CT examination)
  • Hearing or visual impairment that may affect delirium assessment
  • Suspected or confirmed history of alcohol/drug/drug abuse
  • Previous history of mental illness or preoperative use of antipsychotic drugs
  • Moderate and severe renal function damage (blood creatinine \> 2mg/dL or 177mmol/L) or abnormal liver function (alanine aminotransferase\>2 times the upper limit of normal value) or other serious lung diseases
  • Hematologic diseases, bone marrow and/or lymphoid diseases, leukopenia
  • Use immunosuppressive drugs or autoimmune diseases
  • Pregnant
  • Accompanied by other diseases that may affect their survival, such as tumor
  • HIV

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, Beijing Municipality, 100037, China

Location

MeSH Terms

Conditions

Emergence DeliriumHeart Diseases

Condition Hierarchy (Ancestors)

DeliriumConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsNeurocognitive DisordersMental DisordersCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2022

First Posted

November 28, 2022

Study Start

July 1, 2022

Primary Completion

October 31, 2023

Study Completion

October 31, 2023

Last Updated

April 17, 2024

Record last verified: 2024-04

Locations